Pulse Biosciences, Inc. (PLSE) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Revenues:
System Products				0.2	0.4
Cycle Units Products				0.1	0.1
Rest of World				0.1	0.1
North America				0.2	0.3
Total revenues	0.0	0.0	0.0	0.3	0.4	0.8	0.6	0.0
Revenue growth	-100.0%	-100.0%	-100.0%
Cost of goods sold	0.0	0.0	18.0	1.3	0.9	46.2	14.8	14.8
Gross profit	0.0	0.0	-18.0	-1.1	-0.5	-45.4	-14.3	-14.8
Gross margin				-407.2%	-104.7%	-5375.1%	-2486.6%
Selling, general and administrative [+]	3.5	3.7		7.5	10.0	33.8
Sales and marketing				3.7	5.5	14.8
General and administrative	3.5	3.7	0.0	3.8	4.5	19.1	0.0	0.0
Other selling, general and administrative
Research and development	6.7	5.8		5.5	6.8	28.6
Other operating expenses			0.0			-93.7	0.0	1.0
EBITDA [+]	-9.9	-9.3		-13.7	-16.9	-13.0
EBITDA growth	-27.3%	-45.4%	26.3%	-13.8%	-9.6%	0.8%	10.9%	5766.7%
EBITDA margin				-5154.7%	-3816.9%	-1538.4%	-2489.7%
Depreciation	0.1	0.1	-0.2	0.2	0.2	0.5	-0.2	-0.2
EBITA	-10.1	-9.4	-17.9	-13.8	-17.1	-13.5	-14.1	-15.7
EBITA margin				-5225.3%	-3852.9%	-1595.3%	-2460.6%
Amortization of intangibles	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2
EBIT [+]	-10.2	-9.6	-18.1	-14.0	-17.3	-14.1	-14.3	-15.8
EBIT growth	-27.0%	-44.6%	26.3%	-11.5%	-7.9%	1.1%	10.9%
EBIT margin				-5288.3%	-3890.3%	-1674.2%	-2489.7%
Interest expense, net [+]	-0.3	0.2		0.0		0.6
Interest expense		0.2				0.6
Interest income	0.3			0.0
Other income (expense), net			0.0			-0.6	0.0	0.5
Pre-tax income	-9.9	-9.8	-18.0	-14.0	-17.3	-15.4	-14.3	-15.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-9.9	-9.8	-18.0	-14.0	-17.3	-15.4	-14.3	-15.3
Net margin				-5281.5%	-3890.3%	-1826.5%	-2488.2%

Basic EPS [+]	($0.22)	($0.26)	($0.49)	($0.44)	($0.58)	($0.55)	($0.48)	($0.58)
Growth	-49.9%	-54.9%	0.7%	-23.2%	-18.8%	-6.8%	-5.7%	9.9%
Diluted EPS [+]	($0.22)	($0.26)	($0.49)	($0.44)	($0.58)	($0.55)	($0.48)	($0.58)
Growth	-49.9%	-54.9%	0.7%	-23.2%	-18.8%	-6.8%	-5.7%	9.9%

Shares outstanding (basic) [+]	44.5	37.4	37.2	31.5	29.7	28.0	29.6	26.5
Growth	41.3%	25.7%	25.5%	18.9%	14.1%	20.3%	17.4%	23.0%
Shares outstanding (diluted) [+]	44.5	37.4	37.2	31.5	29.7	28.0	29.6	26.5
Growth	41.3%	25.7%	25.5%	18.9%	14.1%	20.3%	17.4%	23.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.